These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 28875989)

  • 1. The Current State of Pharmacological Treatments for Cannabis Use Disorder and Withdrawal.
    Brezing CA; Levin FR
    Neuropsychopharmacology; 2018 Jan; 43(1):173-194. PubMed ID: 28875989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review of outcome domains and measures used in psychosocial and pharmacological treatment trials for cannabis use disorder.
    Lee DC; Schlienz NJ; Peters EN; Dworkin RH; Turk DC; Strain EC; Vandrey R
    Drug Alcohol Depend; 2019 Jan; 194():500-517. PubMed ID: 30530238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological Treatment of Cannabis-Related Disorders: A Narrative Review.
    Gorelick DA
    Curr Pharm Des; 2016; 22(42):6409-6419. PubMed ID: 27549375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex- and Gender-Based Analysis in Cannabis Treatment Outcomes: A Systematic Review.
    Brabete AC; Greaves L; Hemsing N; Stinson J
    Int J Environ Res Public Health; 2020 Jan; 17(3):. PubMed ID: 32019247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and a laboratory model of relapse in cannabis users.
    Herrmann ES; Cooper ZD; Bedi G; Ramesh D; Reed SC; Comer SD; Foltin RW; Haney M
    Psychopharmacology (Berl); 2016 Jul; 233(13):2469-78. PubMed ID: 27085870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cannabis: Use and dependence].
    Dervaux A; Laqueille X
    Presse Med; 2012 Dec; 41(12 Pt 1):1233-40. PubMed ID: 23040955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening Medications for the Treatment of Cannabis Use Disorder.
    Panlilio LV; Justinova Z; Trigo JM; Le Foll B
    Int Rev Neurobiol; 2016; 126():87-120. PubMed ID: 27055612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender differences in cannabis use disorder symptoms: A network analysis.
    Kroon E; Mansueto A; Kuhns L; Filbey F; Wiers R; Cousijn J
    Drug Alcohol Depend; 2023 Feb; 243():109733. PubMed ID: 36565568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial.
    Allsop DJ; Copeland J; Lintzeris N; Dunlop AJ; Montebello M; Sadler C; Rivas GR; Holland RM; Muhleisen P; Norberg MM; Booth J; McGregor IS
    JAMA Psychiatry; 2014 Mar; 71(3):281-91. PubMed ID: 24430917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The marijuana withdrawal syndrome: diagnosis and treatment.
    Haney M
    Curr Psychiatry Rep; 2005 Oct; 7(5):360-6. PubMed ID: 16216154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Cannabis Use Disorder: Current Science and Future Outlook.
    Sherman BJ; McRae-Clark AL
    Pharmacotherapy; 2016 May; 36(5):511-35. PubMed ID: 27027272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabis Use Disorder in Adolescence.
    Simpson AK; Magid V
    Child Adolesc Psychiatr Clin N Am; 2016 Jul; 25(3):431-43. PubMed ID: 27338965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cannabis withdrawal syndrome.
    Budney AJ; Hughes JR
    Curr Opin Psychiatry; 2006 May; 19(3):233-8. PubMed ID: 16612207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychometric modeling of cannabis initiation and use and the symptoms of cannabis abuse, dependence and withdrawal in a sample of male and female twins.
    Gillespie NA; Kendler KS; Neale MC
    Drug Alcohol Depend; 2011 Nov; 118(2-3):166-72. PubMed ID: 21507586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological treatment of cannabis dependence.
    Weinstein AM; Gorelick DA
    Curr Pharm Des; 2011; 17(14):1351-8. PubMed ID: 21524266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Adolescent Cannabis Use Disorders.
    Adams ZW; Marriott BR; Hulvershorn LA; Hinckley J
    Child Adolesc Psychiatr Clin N Am; 2023 Jan; 32(1):141-155. PubMed ID: 36410901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex differences in cannabis withdrawal symptoms among treatment-seeking cannabis users.
    Herrmann ES; Weerts EM; Vandrey R
    Exp Clin Psychopharmacol; 2015 Dec; 23(6):415-21. PubMed ID: 26461168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cannabis--abuse and consequences].
    Wøien VA; Horwitz H; Høgberg LC; Askaa B; Jürgens G
    Ugeskr Laeger; 2015 Feb; 177(6):. PubMed ID: 25650575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trial.
    Levin FR; Mariani JJ; Pavlicova M; Brooks D; Glass A; Mahony A; Nunes EV; Bisaga A; Dakwar E; Carpenter KM; Sullivan MA; Choi JC
    Drug Alcohol Depend; 2016 Feb; 159():53-60. PubMed ID: 26711160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapy for the Treatment of Cannabis Use Disorder: A Systematic Review.
    Kondo KK; Morasco BJ; Nugent SM; Ayers CK; O'Neil ME; Freeman M; Kansagara D
    Ann Intern Med; 2020 Mar; 172(6):398-412. PubMed ID: 32120384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.